You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-TGFB1 (TGFB1) Antibodies

Full name:
anti-Transforming Growth Factor, beta 1 Antibodies (TGFB1)
On www.antibodies-online.com are 397 Transforming Growth Factor, beta 1 (TGFB1) Antibodies from 35 different suppliers available. Additionally we are shipping TGFB1 Kits (166) and TGFB1 Proteins (117) and many more products for this protein. A total of 703 TGFB1 products are currently listed.
Synonyms:
ai39657, betaig-h3, bigh3, cdb1, cdg2, cdgg1, ced, csd, csd1, csd2, csd3, dpd1, ebmd, lap, lcd1, MGC146225, tgf, tgf-beta, TGF-BETA-1, TGF-beta1, TGF-beta5, tgfb, Tgfb-1, TGFB1, TGFB4, tgfb5, tgfbeta, TGFbeta1, TGFBI, wu:fb13a07, xx:ai39657
list all antibodies Gene Name GeneID UniProt
TGFB1 7040 P01137
TGFB1 59086 P17246
TGFB1 21803 P04202

Show all species

Show all synonyms

Most Popular Reactivities for anti-TGFB1 (TGFB1) Antibodies

Select your species and application

anti-Human TGFB1 Antibodies:

anti-Rat (Rattus) TGFB1 Antibodies:

anti-Mouse (Murine) TGFB1 Antibodies:

All available anti-TGFB1 Antibodies

Go to our pre-filtered search.

Top referenced anti-TGFB1 Antibodies

  1. Human Polyclonal TGFB1 Primary Antibody for IF (p), IHC (p) - ABIN724685 : Kou, Hu, Yao, Wang, Shen, Kang, Hong: Transforming growth factor-?1 promotes Treg commitment in nasal polyposis after intranasal steroid treatment. in Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2013 (PubMed)
    Show all 11 references for ABIN724685

  2. Human Polyclonal TGFB1 Primary Antibody for WB - ABIN223608 : Tamaki, Hatano, Taura, Tada, Kodama, Nitta, Iwaisako, Seo, Nakajima, Ikai, Uemoto: CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury. in American journal of physiology. Gastrointestinal and liver physiology 2008 (PubMed)
    Show all 6 references for ABIN223608

  3. Human Polyclonal TGFB1 Primary Antibody for IF, IHC (p) - ABIN656282 : Perez, Sierra, Garcia, Aguirre, Babel, Alvarez, Sanchez, Valdes, Volk, Guzman: Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. in Human immunology 2010 (PubMed)
    Show all 6 references for ABIN656282

  4. Human Polyclonal TGFB1 Primary Antibody for EIA, IF - ABIN955174 : Bran, Sommer, Goessler, Hörmann, Riedel, Sadick: TGF-ß1 antisense impacts the SMAD signalling system in fibroblasts from keloid scars. in Anticancer research 2010 (PubMed)
    Show all 5 references for ABIN955174

  5. Human Monoclonal TGFB1 Primary Antibody for EIA, Func - ABIN114558 : Crawford, Stellmach, Murphy-Ullrich, Ribeiro, Lawler, Hynes, Boivin, Bouck: Thrombospondin-1 is a major activator of TGF-beta1 in vivo. in Cell 1998 (PubMed)
    Show all 4 references for ABIN114558

  6. Human Monoclonal TGFB1 Primary Antibody for FACS, IHC - ABIN969570 : Maeshige, Terashi, Aoyama, Torii, Sugimoto, Usami: Effect of ultrasound irradiation on α-SMA and TGF-β1 expression in human dermal fibroblasts. in The Kobe journal of medical sciences 2011 (PubMed)

  7. Human Polyclonal TGFB1 Primary Antibody for EIA, WB - ABIN401249 : Bourdrel, Lin, Lauren, Elmore, Sugarman, Hu, Westcott: Recombinant human transforming growth factor-beta 1: expression by Chinese hamster ovary cells, isolation, and characterization. in Protein expression and purification 1993 (PubMed)

  8. Human Polyclonal TGFB1 Primary Antibody for IHC, ELISA - ABIN1533412 : Matsumoto, Niimi, Kohyama: Characterization of fibrosis-promoting factors and siRNA-mediated therapies in C-protein-induced experimental autoimmune myocarditis. in Cellular immunology 2012 (PubMed)

  9. Human Monoclonal TGFB1 Primary Antibody for EIA, IHC (p) - ABIN181152 : Sato, Ozaki, Oh, Meguro, Hatanaka, Nagai, Muroi, Ozawa: Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. in Blood 2006 (PubMed)

  10. Cow (Bovine) Polyclonal TGFB1 Primary Antibody for IHC, WB - ABIN2780306 : Cheon, Wei, Gurung, Youn, Bright, Poon, Whetstone, Guha, Alman: Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006 (PubMed)

More Antibodies against TGFB1 Interaction Partners

Rhesus Monkey Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. TGF-beta1 regulated pAKT (show AKT1 Antibodies) and IFNgamma expressions were associated with epithelial cell survival in rhesus macaque colon explants and suggest a potential role of mucosal TGF-beta1 in regulating intestinal homeostasis and EC integrity.

  2. These findings suggest that FBLN5 (show FBLN5 Antibodies) may interfere with choroidal neovascularization by downregulating VEGF (show VEGFA Antibodies), CXCR4 (show CXCR4 Antibodies), and TGFB1 expression and inhibiting choroidl endothelial cell proliferation.

  3. SIV infection of rhesus macaques results in the emergence of IL-17 (show IL17A Antibodies)-expressing cells during the acute phase. This subpopulation appears at day 14 postinfection concomitantly with an increase in TGF-beta and IL-18 (show IL18 Antibodies) expression.

  4. SIV-infected macaques exhibiting progression to AIDS displayed greater expression of TGF-beta and indoleamine 2,3 dioxygenase in CD8 (show CD8A Antibodies)+ T cells from mesentric lymph nodes.

Zebrafish Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. The fine tuning of TGF-beta signaling derives from positive and negative control by Ldb2a (show LDB2 Antibodies).

  2. TGFbeta1a regulates zebrafish posterior lateral line formation via Smad5 (show SMAD5 Antibodies) mediated pathway.

  3. PCSK7 (show PCSK7 Antibodies) is essential for zebrafish development and regulates the expression and proteolytic cleavage of TGFbeta1a.

  4. TGFbeta signaling orchestrates the beneficial interplay between scar-based repair and cardiomyocyte-based regeneration to achieve complete heart regeneration.

  5. TGFbeta1 plays a role in zebrafish keratocyte migration.

  6. data presented show that Zili (show PIWIL2 Antibodies) suppresses TGF-beta signaling by physically associating with Smad4 (show SMAD4 Antibodies) and preventing the formation of Smad2 (show SMAD2 Antibodies)/3/4 and Smad1 (show SMAD1 Antibodies)/5/9/4 complexes

  7. TGF-beta1 acts at multiple sites, including LH receptor (show LHCGR Antibodies), 20beta-HSD (show HAL Antibodies) and membrane progestin receptor-beta (show PAQR8 Antibodies), to inhibit zebrafish oocyte maturation

  8. These data suggest Pez (show PTPN14 Antibodies) plays a crucial role in organogenesis by inducing TGFbeta and epithelial-mesenchymal transition.

  9. Data show that Rock2 (show ROCK2 Antibodies) acts as a negative regulator of the TGFbeta signaling pathway.

Xenopus laevis Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. These data indicate that TGF-beta signaling is crucial for the function of the transition zone, which in turn may affect the regulation of cilia length.

  2. R-Smads are the key components of TGFbeta beta signals in germ layer induction. SCP3 (show SYCP3 Antibodies) serves as a vegetally enriched, intrinsic factor (show GIF Antibodies) to ensure a prepared status of Smads for their activation.

  3. the present in vitro system, which permits not only the cell contraction-mediated cell sorting but also the TGF-b-directed mesodermal induction such as cartilage formation, may fairly reflect the embryogenesis in vivo.

  4. Loss of XTgfbi impaired blastopore formation and dorsal tissue morphogenesis.

  5. TGF-beta signaling has a role in nuclear localization of transcription factor Smad4 (show SMAD4 Antibodies)

  6. sortilin (show SORT1 Antibodies) negatively regulates TGF-beta signaling by diverting trafficking of precursor proteins to the lysosome during transit through the biosynthetic pathway

Human Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. Paracrine Effect of Degenerated Disc Cells on Healthy Human Nucleus Pulposus Cells Is Mediated by MAPK (show MAPK1 Antibodies) and NF-kappaB (show NFKB1 Antibodies) Pathways and Can Be Reduced by TGF-beta1

  2. these results suggest that cytokeratin 18 (show KRT18 Antibodies) critically contributes to initiating TGF-beta1-induced EMT (show ITK Antibodies) via the smad 2 (show SMAD2 Antibodies)/3-mediated regulation of snail (show SNAI1 Antibodies) and slug (show SNAI2 Antibodies) expression in breast epithelial cells.

  3. Craniofacial deformities seen in Loeys-Dietz Syndromes patients may reflect altered TGFbeta signaling in neural crest derivatives.

  4. A constant observation was that 1,25(OH)2D3 or synthetic ligands via the active vitamin D receptor (VDR) impede transforming growth factor (TGF)-beta/mothers against decapentaplegic homologs (SMADs) signaling in myofibroblasts regardless of the initiating insult. The translational impact of 1,25(OH)2D3 in targetting stromal CAFs is discussed

  5. these results suggest that TGF-beta1 stimulates HSC-4 cell invasion through the Slug (show SNAI2 Antibodies)/Wnt-5b (show WNT5B Antibodies)/MMP-10 (show MMP10 Antibodies) signalling axis.

  6. TGFbeta1 was the direct target of miR (show MLXIP Antibodies)-663 and mediated the effect of miR (show MLXIP Antibodies)-663 on papillary thyroid carcinoma development. By targeting TGFbeta1, miR (show MLXIP Antibodies)-663 efficiently regulates the expression of epithelial-mesenchymal transition markers and matrix metalloproteinases.

  7. overexpression of miR (show MLXIP Antibodies)-93 in lung cancer cells promoted TGF-b-induced EMT (show ITK Antibodies) through downregulation of NEDD4L (show NEDD4L Antibodies). The analysis of publicly available gene expression array datasets indicates that low NEDD4L (show NEDD4L Antibodies) expression correlates with poor outcomes among patients with lung cancer, further supporting the oncogenic role of miR (show MLXIP Antibodies)-93 in lung tumorigenesis and metastasis.

  8. The molecular pathogenesis of radiotherapy-induced muscle fibrosis involves the TGF-beta1 pathway and its repression of MyoD (show MYOD1 Antibodies) expression. Our results suggest a correlation between traditional swallow therapy /neuromuscular electrical stimulation combined therapy and the restoration of TGF-beta1/MyoD (show MYOD1 Antibodies) homeostasis in cervical muscles.

  9. Profiles of N-glycopeptides / N-glycoproteins / N-glycosites in LX-2 cells, with and without activation by TGFB1, were identified and compared using hydrazide chemistry enrichment coupled with liquid chromatography - mass spectrometry analysis. A total of 103 non-redundant N-glycopeptides, with 107 glycosylation sites from 86 N-glycoproteins, were identified in activated and quiescent LX-2 cells respectively.

  10. It has now been shown that CTGF (show CTGF Antibodies) expression is essential for multiplication of fibroblasts, and in its absence, the fibroblasts become unresponsive to agents like TGF-beta1 that normally enhance their growth

Pig (Porcine) Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. The results indicated that TGF-beta-1 was associated with the restoration of intestinal morphology and barrier function following weaning stress.

  2. Data (including data from in vitro and in vivo experiments) suggest that day 14 elongated conceptus secretes proteins that up-regulate TGFbeta1 mRNA and TGFbeta1 expression in endometrium; TGFbeta1 may be important during pregnancy maintenance.

  3. The effects of semen, spermatozoa in extender, or extender alone on the expression of TGF-beta1, IL-10 (show IL10 Antibodies), and IL-6 (show IL6 Antibodies) in ovarian follicles are reported.

  4. Dietary (1,3/1,6)-beta-D-glucan reduced the mRNA expression of transforming growth factor (TGF) beta2 (show TGFB2 Antibodies) and tended to reduce the mRNA expression of TGF-beta1 in lung tissue of neonatal piglet.

  5. TGF-beta1, via TGF-beta1 receptor I and p38 MAPK (show MAPK14 Antibodies) signaling, reduces CFTR (show CFTR Antibodies) expression to impair CFTR (show CFTR Antibodies)-mediated anion secretion, which would likely compound the effects associated with mild CFTR (show CFTR Antibodies) mutations and ultimately would compromise male fertility.

  6. High yield isolation of BMP-2 (show BMP2 Antibodies) from bone and in vivo activity of a combination of BMP-2 (show BMP2 Antibodies)/TGF-beta1.

  7. Boar seminal plasma contained TGF- beta1 and IL-10 (show IL10 Antibodies) but with high individual variation.

  8. The present study was aimed to determine the association between metalloproteinase 3 (MMP3 (show MMP3 Antibodies)), transforming growth factor beta 1 (TGFbeta1) and collagen type X alpha I (COL10A1 (show COL10A1 Antibodies)) gene polymorphisms with traits related to leg weakness in pigs.

  9. Inhibition of transforming growth factor beta-1 augments liver regeneration after partial portal vein ligation in a porcine experimental model.

  10. TGF-beta prevents excessive heart valve growth under normal physiological conditions while it promotes cell proliferation in the early stages of repair.

Cow (Bovine) Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. The results identify TGFB1 and ESRRA (show ESRRA Antibodies) as likely transcriptional regulators of rumen epithelial development and energy metabolism, respectively, and provide targets for modulation of rumen development and function in the growing calf.

  2. the combined treatment with TGF-beta1 and BMP-7 (show BMP7 Antibodies) or treatment first with TGF-beta1 followed by BMP-7 (show BMP7 Antibodies) was more effective than other treatment groups in both chondrogenic differentiation and SZP (show PRG4 Antibodies) secretion.

  3. Tenascin-X (show TNXB Antibodies) promotes activation of latent TGF-beta1 and subsequent epithelial to mesenchymal transition in mammary epithelial cells.

  4. a detailed computational model for TGF-beta signalling that incorporates elements of previous models together with crosstalking between Smad1 (show SMAD1 Antibodies)/5/8 and Smad2 (show SMAD2 Antibodies)/3 channels through a negative feedback loop dependent on Smad7 (show SMAD7 Antibodies).

  5. Endogenous TGF-beta1 became more bioactive following activation of the transgene protein product in chondrocytes.

  6. A novel peptide, P2K, regulating TGF-beta1 signaling had an anabolic effect on bovine intervertebral disc cells and rabbit degenerated discs.

  7. Data show that TGF-beta pathways operate during ovarian fetal development, and fibrillin 3 (show FBN3 Antibodies) is highly expressed at a critical stage early in developing human and bovine fetal ovaries.

  8. Role of TGF-beta1 and TNF-alpha (show TNF Antibodies) in IL-1beta (show IL1B Antibodies) mediated activation of proMMP-9 in pulmonary artery smooth muscle cells: involvement of an aprotinin sensitive protease.

  9. vascular endothelial growth factor indirectly stimulates smooth muscle cell proliferation and migration through the modulation of basic fibroblast growth factor (show FGF2 Antibodies) and transforming growth factor beta(1) released by endothelial cells

  10. Data show that as antral follicles develop, transforming growth factor (TGF)-beta3 (show TGFB3 Antibodies) is the most abundant TGF-beta isoform and TGF-beta1 protein levels decline in large follicles.

Mouse (Murine) Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. Pro-fibrotic cardiac effect of miR (show MLXIP Antibodies)-328 was mediated by down-regulating TGFbR3 (show TGFBR3 Antibodies) and up-regulating TGFb1.

  2. Activation of CB2 (show CNR2 Antibodies) ameliorates myocardial fibrosis via Nrf2 (show NFE2L2 Antibodies)-mediated inhibition of TGF-beta1/Smad3 (show SMAD3 Antibodies) pathway in mice with myocardial infarction.

  3. Data show that regulation of interleukin-6 (IL-6 (show IL6 Antibodies)) on transforming growth factor beta1 (TGFbeta1) and microRNA miR (show MLXIP Antibodies)-29 pathway reduced myocardial fibrosis and improved cardiac function of diabetic mice.

  4. T3 reduces occupancy of SMAD (show SMAD1 Antibodies)-binding elements in response to TGF-beta, reducing histone acetylation and inhibiting transcription. In agreement with this transcriptional cross-talk, T3 is able to antagonize fibrotic processes in vivo.

  5. This study found evidence of increased leukocyte phosphorylated-Smad2 (show SMAD2 Antibodies)/3 staining in both single leukocytes and platelet-leukocyte aggregates in mice that developed aortic valve stenosis, suggesting the presence of increased circulating active TGF-beta1.

  6. Findings establish that transforming growth factor-beta1 activates TGF-beta receptor-I and its downstream p38 MAPK (show MAPK14 Antibodies) and PI3K-Akt (show AKT1 Antibodies) signaling pathways in microglia to protect against dopaminergic neuronal loss that characterizes in Parkinson's disease.

  7. The findings in this study strongly suggest the following: i) that VEGF-C (show VEGFC Antibodies) promotes the proliferative activity and migratory ability of mesenchymal stem cell ; and ii) VEGF-C (show VEGFC Antibodies) and Tgfb reciprocally regulate mesenchymal stem cell commitment to differentiation into lymphatic endothelial or osteoblastic phenotypes, respectively.

  8. Interactions among the TGF-beta signalling pathways, Jagged2 (show JAG2 Antibodies)/Notch1 (show NOTCH1 Antibodies) signalling pathways and epigenetic modifications regulate the expansion of lingual epithelial stem cells.

  9. tumor antigen-specific vaccination in combination with focal radiation therapy reversed tolerance and improved survival. This treatment regimen was associated with increased polyfunctionality of CD8 (show CD8A Antibodies) T cells, elevated T effector to T regulatory cell ratios, and decreased TGFbeta secretion from microglia.

  10. TGF-beta1 increased the expression of TREM-1 (show TREM1 Antibodies) in mouse macrophages partly via the transcription factor AP-1 (show JUN Antibodies).

Rabbit Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. study suggested that TGF-beta1/Smad3/smad7 is a major pathway which plays an important role in the regulation of the IUA and specific inhibitor of Smad3 (SIS3) may provide a new therapeutic strategy for IUA.

  2. cell therapy promoted TGF-beta1 expression in nucleus pulposus, leading to anti-inflammatory effects via the inhibition of NF-kappaB (show NFKB1 Antibodies), and the amelioration of disc degradation.

  3. that prenatal tracheal occlusion increases TGF-beta/Rho kinase (show ROCK1 Antibodies) pathway, myofibroblast differentiation, and matrix deposition in neonatal rabbit and human congenital diaphragmatic hernia lungs

  4. observation. Based on the above results, we conclude that TGF-beta1-immobilized PLGA-gelatin scaffold seeded with ASCs considerably enhances the quality of the tissue-engineered cartilage, therefore, advancing the field of cartilage tissue engineering

  5. Smad7 (show SMAD7 Antibodies) plays a crucial role in antagonizing epithelial-mesenchymal transition induced by TGFbeta signaling and is a Notch (show NOTCH1 Antibodies) signaling target in limbal epithelial stem cells.

  6. the role of IL-10 in inhibited allograft rejection may be associated with CD4+CD25+ regulatory T cells and IL-10, and may be independent of TGF-b

  7. After NOTCH1 (show NOTCH1 Antibodies) knockdown and TGFB1 stimulation, rabbit mesenchymal stem cells expressed higher levels of proteoglycan (show Vcan Antibodies) and collagen II.

  8. TGF-beta1 gene transcription significantly correlates with the surgical vaginal and dermal wound closure rate.

  9. A novel peptide, P2K, regulating TGF-beta1 signaling had an anabolic effect on bovine intervertebral disc cells and rabbit degenerated discs.

  10. Wound closure was significantly protracted (P < 0.02), whereas TGFbeta1 gene expression was significantly increased (P < 0.0001) during the wound healing process in oophorectomised rabbits.

Guinea Pig Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. TGF beta is involved in the pathogenesis of tympanosclerosis.

  2. There was significantly higher expression of TGF-beta1 and MMP-9 (show MMP9 Antibodies) in nasal mucosa of experimental allergic rhinitis guinea pigs than in controls.

Horse (Equine) Transforming Growth Factor, beta 1 (TGFB1) interaction partners

  1. Within the limitations of the study design, production of COMP (show COMP Antibodies) during healing of skin wounds does not appear to be influenced by wound type or anatomic site, nor does it appear to be correlated with TGF-beta1 concentrations.

  2. Peritoneal TGF-beta(1) concentration was higher in horses with severe gastrointestinal diseases, in horses with an altered peritoneal fluid, and in nonsurvivors.

TGFB1 Antigen Profile

Antigen Summary

This gene encodes a member of the transforming growth factor beta (TGFB) family of cytokines, which are multifunctional peptides that regulate proliferation, differentiation, adhesion, migration, and other functions in many cell types. Many cells have TGFB receptors, and the protein positively and negatively regulates many other growth factors. The secreted protein is cleaved into a latency-associated peptide (LAP) and a mature TGFB1 peptide, and is found in either a latent form composed of a TGFB1 homodimer, a LAP homodimer, and a latent TGFB1-binding protein, or in an active form composed of a TGFB1 homodimer. The mature peptide may also form heterodimers with other TGFB family members. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease.

Alternative names and synonyms associated with TGFB1

  • transforming growth factor, beta 1 (TGFB1) antibody
  • transforming growth factor, beta 1a (tgfb1a) antibody
  • transforming growth factor, beta-induced, 68kDa (TGFBI) antibody
  • transforming growth factor, beta-induced, 68kDa (tgfbi) antibody
  • transforming growth factor, beta-induced, 68kDa (LOC100227786) antibody
  • transforming growth factor beta 1 (TGFB1) antibody
  • transforming growth factor, beta 1 (Tgfb1) antibody
  • transforming growth factor, beta 1 (tgfb1) antibody
  • transforming growth factor, beta 1 (tgf) antibody
  • ai39657 antibody
  • betaig-h3 antibody
  • bigh3 antibody
  • cdb1 antibody
  • cdg2 antibody
  • cdgg1 antibody
  • ced antibody
  • csd antibody
  • csd1 antibody
  • csd2 antibody
  • csd3 antibody
  • dpd1 antibody
  • ebmd antibody
  • lap antibody
  • lcd1 antibody
  • MGC146225 antibody
  • tgf antibody
  • tgf-beta antibody
  • TGF-BETA-1 antibody
  • TGF-beta1 antibody
  • TGF-beta5 antibody
  • tgfb antibody
  • Tgfb-1 antibody
  • TGFB1 antibody
  • TGFB4 antibody
  • tgfb5 antibody
  • tgfbeta antibody
  • TGFbeta1 antibody
  • TGFBI antibody
  • wu:fb13a07 antibody
  • xx:ai39657 antibody

Protein level used designations for TGFB1

transforming growth factor beta1 , transforming growth factor, beta 1 , transforming growth factor, beta-induced, 68kDa , transforming growth factor-beta-induced protein ig-h3-like , transforming growth factor beta-1-like , TGF-beta-1 , transforming growth factor beta 4 , transforming growth factor beta-1 , TGF-beta 1 protein , latency-associated peptide , transforming growth factor, beta 1 (Camurati-Engelmann disease) , transforming growth factor-beta-1 , TGF-beta 1 , transforming growth factor-beta 1 , transforming growth factor, beta-1 , transforming growth factor beta 1 , regulatory protein , transforming growth factor-beta , TGF-beta-5 , tgf beta , tgf-beta 5 , transforming gorwth factor-Beta5 , transforming growth factor-B5 , transforming growth factor-beta 5 , Transforming growth factor beta-1

GENE ID SPECIES
574135 Macaca mulatta
359834 Danio rerio
768263 Felis catus
456060 Pan troglodytes
462081 Pan troglodytes
481519 Canis lupus familiaris
495971 Xenopus laevis
712503 Macaca mulatta
779782 Xenopus (Silurana) tropicalis
100227786 Taeniopygia guttata
100397340 Callithrix jacchus
100401979 Callithrix jacchus
100441300 Pongo abelii
100459982 Pongo abelii
100580274 Nomascus leucogenys
100581386 Nomascus leucogenys
100873157 Gallus gallus
7040 Homo sapiens
397078 Sus scrofa
443417 Ovis aries
59086 Rattus norvegicus
403998 Canis lupus familiaris
282089 Bos taurus
21803 Mus musculus
100008645 Oryctolagus cuniculus
100135628 Cavia porcellus
100033900 Equus caballus
397778 Xenopus laevis
100136774 Oncorhynchus mykiss
Selected quality suppliers for anti-TGFB1 (TGFB1) Antibodies
Did you look for something else?